Carisma Therapeutics to Participate in H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference

Rhea-AI Summary

Carisma Therapeutics (Nasdaq: CARM), a pioneer in macrophage-focused therapeutics, has announced its participation in the upcoming H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference. The company's Co-founder and Chief Scientific Officer, Michael Klichinsky, PharmD, PhD, will be presenting at the conference on Tuesday, February 25 at 10:30 am ET.

Interested parties can access an audio webcast of the presentation through the Company's Investor Events section on their Investor Relations webpage. The recording will remain available for a time after the event.

PHILADELPHIA, Feb. 19, 2025 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a leader in macrophage-focused therapeutics, today announced that Michael Klichinsky, PharmD, PhD, Co-founder and Chief Scientific Officer, will participate in the H.C. Wainwright 3^rd Annual Cell Therapy Virtual Conference on Tuesday, February 25 at 10:30 am ET.

An audio webcast of the event will be available on the Company's Investor Events section of the Investor Relations webpage and will be archived for a limited time following the event.

About Carisma

Carisma Therapeutics is a biopharmaceutical Company pioneering macrophage engineering to develop groundbreaking therapies for fibrosis, cancer, and other diseases. With a strong commitment to patient-centric innovation, Carisma aims to deliver scalable, next-generation solutions that transform treatment paradigms. Carisma is headquartered in Philadelphia, PA. For more information, please visit www.Carismatx.com.

Investors:
Shveta Dighe
investors@carismatx.com

Media Contact:
Julia Stern
(763) 350-5223
jstern@realchemistry.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/carisma-therapeutics-to-participate-in-hc-wainwright-3rd-annual-cell-therapy-virtual-conference-302379463.html

SOURCE Carisma Therapeutics Inc.

FAQ

When is Carisma Therapeutics (CARM) presenting at the H.C. Wainwright Cell Therapy Conference?

Carisma Therapeutics will present at the H.C. Wainwright Cell Therapy Conference on Tuesday, February 25 at 10:30 am ET.

How can investors access CARM's presentation at the H.C. Wainwright Conference?

Investors can access the audio webcast through the Investor Events section of Carisma Therapeutics' Investor Relations webpage.

Who will represent CARM at the H.C. Wainwright Cell Therapy Conference?

Michael Klichinsky, PharmD, PhD, Co-founder and Chief Scientific Officer, will represent Carisma Therapeutics at the conference.

Will CARM's H.C. Wainwright Conference presentation be available for replay?

Yes, the audio webcast will be archived and available for a time following the event on the company's Investor Relations webpage.